Tokio Marine Asset Management’s TG Therapeutics TGTX Stock Holding History

Tokio Marine Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.9K	Buy	+1,509	New	+$61.8K	﹤0.01%	535

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Tokio Marine Asset Management's TGTX Position: Q2 2026 in Review

Tokio Marine Asset Management opened a new position in TG Therapeutics (TGTX) in Q2 2026: 1,509 shares worth $82.9K. The stake represents ﹤0.01% of the portfolio and ranks #535 among its holdings.

194 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Tokio Marine Asset Management held 1,509 shares of TG Therapeutics worth $82.9K as of Q2 2026.
TG Therapeutics was a new Tokio Marine Asset Management position in Q2 2026.
TG Therapeutics made up ﹤0.01% of Tokio Marine Asset Management's portfolio in Q2 2026, its #535 holding.
194 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.